Innovation Showcase: Innovative 3D Printed Intravaginal Ring, ANLO102: Sustained Release of Progesterone for Infertility Treatment

AnelleO is harnessing the advancements in the speed and scale of 3D printing technology for novel solutions in Women’s Health. Intravaginal Rings (IVR) offer a unique platform for sustained delivery of therapeutics – a non-invasive, self-administered and retrievable platform that can deliver drugs over a period of weeks or months. To-date, IVR technology has been limited to a few successes due to inherent limitations of current manufacturing by injection molding or extrusion. The design flexibility, rapid prototyping, and cost-effective manufacturing of digital light synthesis (DLS) 3D printing allows AnelleO to develop and manufacture IVRs specifically matched to the unique characteristics of the molecule and indication.
AnelleO’s lead product is ANLO102 – a self-administered, non-invasive multi-week alternative to daily progesterone supplementation alongside Assisted Reproductive Technologies (ART) for women undergoing fertility treatment.
AnelleO is the first company to develop any 3D printed IVR. The successful production of ANLO102 will validate our technology as a platform for IVRs for multiple indications, e.g., contraception, HIV/STIs prevention, endometriosis, vaginal atrophy, and gynecology oncology.